Sai Parenteral – IPO
Sai Parenteral – IPO Details
| IPO Date | March 24, 2026 to March 27, 2026 |
| Listing Date | April 2, 2026 |
| Face Value | ₹ 5 / Share |
| Price Band | ₹ 372 to ₹ 392 / Share |
| Lot Size | 38 Shares |
| Total Issue Size | 1,04,28,288 (Aggregating up to ₹409 Cr) |
| Fresh Issue | 72,70,408 (Aggregating up to ₹285 Cr) |
| Offer for Sale | 31,57,880 (Aggregating up to ₹124 Cr) |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 3,69,08,823 |
| Share holding post issue | 4,41,79,231 |
| Market Maker portion |
Sai Parenteral Timeline (Tentative Schedule)
Sai Parenteral IPO opens on March 24, 2026, and closes on March 27, 2026.
| IPO Open Date | March 24, 2026 |
| IPO Close Date | March 27, 2026 |
| Basis of Allotment | March 30, 2026 |
| Initiation of Refunds | April 1, 2026 |
| Credit of Shares to Demat | February 1, 2026 |
| Listing Date | April 2, 2026 |
| Cut-off time for UPI mandate confirmation | March 27, 2026 |
Sai Parenteral IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | Rs.14,896 |
| Retail (Max) | 13 | 494 | Rs.193,648 |
| S-HNI (Min) | 14 | 532 | Rs.208,544 |
| S-HNI (Max) | 67 | 2,546 | Rs.998,032 |
| B-HNI (Min) | 68 | 2,584 | Rs.1,012,928 |
| HNI (Min) |
Sai Parenteral IPO Promoter Holding
| Share Holding Pre Issue | 3,69,08,823 |
| Share Holding Post Issue | 4,41,79,231 |
Sai Parenteral IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 50% of the Net Offer |
|
| NII (HNI) Shares Offered | Not less than 15% of the Net Offer |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 35% of the Net Offer |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Sai Parenteral IPO Anchor Investors Details
| Bid Date | 2026-03-23 |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | April 29, 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | June 28, 2026 |
About Sai Parenteral
Sai Parenteral's Ltd. is a multifaceted pharmaceutical formulations firm that was founded in 2001 and has experience in production, research, and development.
Branded generic formulations and Contract Development and Manufacturing Organization (CDMO) goods and services for both local and foreign markets comprise the company's two business sectors.
Cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics, and dermatology are only a few of the therapeutic categories covered by the product range. Offerings include injectables, pills, capsules, liquid orals, and ointments, among other dosage forms.
In India, Sai Parenteral's serves a broad range of clients, including pharmaceutical firms, public and private hospitals, mega stockists, and central and state government organizations.
After purchasing two globally approved facilities in Hyderabad, Telangana, the company began exporting in FY 2023 and currently provides regulated and semi-regulated markets in Australia, New Zealand, Southeast Asia, the Middle East, and Africa.
Five manufacturing plants in India are owned and run by the firm. A GMP-compliant injectable unit, a WHO-GMP injectable unit, a solid oral dosage unit recognized by TGA-Australia and PIC/S, and a WHO-GMP cephalosporin facility are all situated in Hyderabad, Telangana. In Ongole, Andhra Pradesh, its fully owned subsidiary, Revat Laboratories, runs a GMP-certified plant.
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 16.82% |
| ROCE | 28.92% |
| Debt/Equity | |
| RoNW | 15.09% |
| P/BV | 10.89 |
| PAT Margin (%) | 8.88% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 5.43 | |
| P/E (x) | 72.19 |
Objects of the Issue (Sai Parenteral IPO Objectives)
Sai Parenteral Contact Details
Sai Parenteral’s Limited Plot No. 39 5th floor, Lavanya Arcade, Jayabheri Enclave Gachibowli, K.V. Rangareddy, Seri Lingampally Hyderabad, Telangana, 500032 Phone: +91 79979 91301 Email: [email protected] Website: https://www.saiparenterals.com/ |
Sai Parenteral IPO Registrar
Bigshare Services Pvt. Ltd. Phone: +91-22-6263 8200 Email: [email protected] Website: https://ipo.bigshareonline.com/IPO_Status.html |